13:40 IST
BSE
Credit Rating
Aptus Pharma Credit Rating
Aptus Pharma Limited has been assigned a 'CARE BB; Stable' issuer rating by CARE Ratings. The rating reflects the company's modest scale of operations.
Aptus Pharma Ltd
- Share price
- ₹385.20
- Market cap
- ₹660.6 Cr
- Revenue (annual)
- ₹46.57 Cr
- Net profit (annual)
- ₹4.62 Cr
- P/E (TTM)
- 143.0×Sector 47.3×
- Promoter holding
- 72.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Promoter Buying (Off-Market) 4Fund Raise 3Board Meeting Outcome 3Other Announcement 2Financial Results 2Capital Structure Change 2Board Meeting Date 2Annual General Meeting 2Results Update 1Promoter Selling (Off-Market) 1Earnings Call 1Credit Rating 1Capacity Expansion 1Annual Report 1
Time
1 announcement with these filters